Tumour necrosis factor-α up-regulates decay-acceleratiag factor gene expression in human intestinal epithelial cells

Immunology

Volumn 90, Issue 3, 1997, Pages 358-363

  Andoh, A ^a   Fujiyama, Y ^a   Sumiyoshi, K ^a   Sakumoto, H ^a   Okabe, H ^a   Bamba, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ARTICLE; CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL;

EID: 0031048165     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.1997.00358.x     Document Type: Article

References (35)

1. KINOSHITA T., MEDOF M.E., SILBR R. & NUSSENZWEIG V. (1985) Distribution of decay-acceleratingfactorin the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162, 75.
2. MEDOF M.E., WALTER E.I., RUTGERS J.L., KNOWLES D.M. & NUSSENZWEIG V. (1987) Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and body fluids. J Exp Med 165, 848.
3. MORGAN B.P. (1985) Complement regulatory molecules: application to therapy and transplantation, Immunol Today 16, 257.
4. KOOYMAN D.L., BYRNE G.W., MCCLELLAN S. et al. (1995) In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269, 89.
5. BIVIC A.L., QUARONI A., NICHOLS B. & RODRIGUEZ-BOULAN E. (1990) Biogenetic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line. J Cell Biol 111, 1351.
6. KORETZ K., BRUDERLEIN S. & MOLLER P. (1992) Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer 1992 66, 810.
7. INOUE H., MIZUNO M., UESU T., UEKI T. & TSUJI T. (1994) Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. Acta Med Okayama 48, 271.
8. OHSHIO G., FURUKAWA F., MANABE T., TOBE T. & HAMASHIMA Y. (1988) Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction. Dig Dis Sci 33, 570.
9. ANDOH A., FUJIYAMA Y., SUMIYOSHI K. & BAMBA T. (1996) Local secretion of complement C3 in the exocrine pancreas: ductal epithelial cells as a possible biosynthetic site. Gastroenterology 110 (1919)
10. AHRENSTEDT O., KNUTSON L., NILSSON B., NILSSON-EKDAHL K., ODLIND K. & HALLGREN R. (1990) Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 322, 1345.
11. ANDOH A., FUJIYAMA Y., BAMBA T. & HOSODA S. (1993) Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 151, 4239.
12. ANDOH A., FUJIYAMA Y., SUMIYOSHI K. et al. (1995) Modulation of complement C3, C4, and factor B production in human intestinal epithelial cells: differential effects of TNF-α, IFN-γ, and IL-4. Pathophysiology 2, 251.
13. MOLMENTI E.P., ZIAMBARAS T. & PERLMUTTER D.H. (1993) Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 268, 14116.
14. UESU T., MIZUNO M., INOUE H., TOMODA J. & TSUJI T. (1995) Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab Med 72, 587.
15. ANDOH A., FUJIYAMA Y., SUMIYOSHI K., SAKUMOTO H. & BAMBA T. (1996) Interleukin-4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology 111, 911.
16. ZWEIBAUM A., LABURTHE M., GRASSET E. & LOUVARD D. (1991) Use of cultured cell lines in studies of intestinal cell differentiation and function. In: Handbook of physiology, Section 6: The gastrointestinal system (eds S.G. Schultz, M. Field, R.A. Frizzell & B.B. Bauner), Vol. 4, p. 223, American physiological society, Bethesda, MD.
17. HEKMATI M., POLAK-CHARCON S. & BEN-SHAUL Y. (1990) A morphological study of a human adenocarcinoma cell line (HT-29) differentiating in culture. Similarities to intestinal embryonic development. Cell Differ Dev 31, 207.
18. DHARMSATHAPHORN K., MCROBERTS J.A., MANDEL K.G., TISDALE L.D. & MASUI H. (1984) A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol 246, G204.
19. VASSALLI P. (1992) The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10, 411.
20. MURCH S.H., LAMKIN V.A., SAVAGE M.O., WALKER-SMITH J.A. & MACDONALD T.T. (1991) Serum concentrations of tumor necrosis factor-α in childhood chronic inflammatory bowel disease. Gut 32, 913.
21. BRAEGGER C.P., NICHOLLS S.W., MURCH S.H., STEPHENS S. & MACDONALD T.T. (1992) Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339, 89.
22. BREESE E.J., MICHIE C.A.. NICHOLLS S.W. et al. (1994) Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106, 1455.
23. BRYANT R.W., GRANZOW C.A., SIEGEL M.I., EGAN R.W. & BILLAH M.M. (1990) Phorbol esters increase synthesis of decay-accelerating factor, a phosphatidylinositol-anchored surface protein, in human endothelial cells. J Immunol 144, 593.
24. BRYANT R.T., GRANZOW C.A., SIEGEL M.I., EGAN R.W. & BILLAH M.M. (1991) Wheat germ agglutinin and other selected lectins increase synthesis of decay-accelerating factor in human endothelial cells. J Immunol 147, 1856.
25. CHOMCZYNSKI P. & SACCHI N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162, 156.
26. CARAS I.W., DAVITZ M.A., RHEE L., WEDDELL G., MARTIN D.W. & NUSSENZWEIG V. (1987) Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Science 325, 545.
27. POST T.W., ARCE M.A., LISZEWSKI K., THOMPSON E.S., ATKINSON J.P. & LUBLIN D.M. (1990) Structure of the gene for human complement protein decay accelerating factor. J Immunol 147, 740.
28. HOLMES C.H., SIMPSON K.N., WAINWRIGHT S.D. et al. (1990) Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 144, 3099.
29. SHAW G. & KAMEN R. (1996) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46, 659.
30. ZUBIAGA A.M., MUNOZ E. & HUBER B.T. (1991) Superinduction of IL-2 gene transcription in the presence of cycloheximide. J Immunol 146, 3857.
31. RIESBECK K., SIGVARDSSON M., LEANDERSON T. & FORSGREN A. (1994) Superinduction of cytokine gene transcription by cipro-floxacin. J Immunol 153, 343.
32. SCHUERER-MALY C.C., ECKMANN L., KAGNOF M.F., FALCO M.T. & MALY FE. (1994) Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 81, 85.
33. MULLIN J.M. & SNOCK KV. (1990) Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res 50, 2172.
34. DEALTRY G.B., NAYLOR M.S., FIERS W. & BALKWILL F.R. (1987) The effect of recombinant tumor necrosis factor on growth and macromolecular synthesis of human epithelial cells. Exp Cell Res 170, 428.
35. ABREU-MARTIN M.T., VIDRICH A., LYNCH D.H. & TARGAN S.R. (1995) Divergent induction of apoptosis and 1L-8 secretion in HT-29 cells in response to TNF-α and ligation of Fas antigen. J Immunol 155, 4147.